Nearly one out of every three people in the world (approximately 2 billion people) has been infected by HBV, and one in twelve (more than 520 million people) live with chronic HBV or HCV infection.
全世界每三人中就有将近一人感染乙肝病毒(约20亿人),而每十二人中就有一人(5.2亿多人)的生活与慢性乙型肝炎或慢性乙肝病毒感染相伴。
One class of interferons is used to treat chronic infection with HBV and HCV.
其中一类的干扰素常被用来治疗乙肝或丙肝感染。
Expected complications of chronic HCV infection, which are the most common indications for liver transplant, include cirrhosis, end-stage liver disease, and liver cancer.
预期的慢性HCV感染的并发症,包括肝硬化,末期肝病以及肝癌,这可能是最常见的肝移植的指标。
应用推荐